Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

September 26, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400051 Dalal Street, Mumbai - 400001 NSE Symbol: PANACEABIO BSE Scrip Code: 531349 Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) Dear Sir / Madam, Pursuant to Regulation 30 read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we would like to inform you that the Company has received on September 26, 2026, four (4) Demand Orders dated September 25, 2026, from the Office of the Assistant Commissioner of Income Tax, Delhi under Section 156 of the Income Tax Act, 1961 (“Act”) imposing penalty on account of alleged misreporting / under reporting of income, resulting into demand aggregating to ~₹9.82 Crore as per details given in the enclosed Annexure. The requisite details as required under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and Industry Standards on Regulation 30 of SEBI LODR Regulations is annexed herewith as Annexure A. This is for your kind information and record please. Thanking you, Sincerely yours, For Panacea Biotec Limited Ankit Jain General Manager – Legal & Company Secretary Encl. As above Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com Annexure A Details required under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and Industry Standards on Regulation 30 of SEBI LODR Regulations # Particulars Details 1 Name of the Listed Entity Panacea Biotec Limited 2 Type of communication received The Company has received four Demand Orders from Office of the Assistant Commissioner of Income Tax, Delhi under the Income Tax Act, 1961 (“Act”) 3 Date of receipt of communication 26.09.2026 4 Authority from whom communication Office of the Assistant Commissioner of Income Tax, Delhi received 5 Brief summary of the material Four Demand Orders u/s 156 of the Act raising aggregate demand contents of the communication of ~₹9.82 Crore towards penalty on account of alleged misreporting received, including reasons for receipt / under reporting of income. of the communication 6 Period for which communication Assessment Years from 2014-15 to 2016-17 and 2018-19. would be applicable, if stated 7 Expected financial implications on the Based on the Company’s assessment, the aforesaid demand is not listed company, if any maintainable, and the Company is taking all necessary steps including filing an Appeal with appellate authority against the said demand. The Company does not envisage any significant impact on financial, operation or other activities of the Company. 8 Details of any aberrations/non- Not Applicable compliances identified by the authority in the communication 9 Details of any penalty or restriction or The department has alleged misreporting / under reporting of sanction imposed pursuant to the income in the assessment orders passed earlier and has imposed communication penalty of ~₹9.82 Crore under Section 270A of the Act. 10 Action(s) taken by listed company Not Applicable with respect to the communication 11 Any other relevant information Not Applicable Thanking you, Sincerely yours, For Panacea Biotec Limited Ankit Jain General Manager – Legal & Company Secretary Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com